+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Relmada Therapeutics Inc (RLMDD) - Financial and Strategic SWOT Analysis Review

  • ID: 4278704
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData

Relmada Therapeutics Inc (Relmada Therapeutics), formerly known as Camp Nine, Inc is a clinical stage specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. Its product pipeline includes REL-1017 d-Methadone, an antagonist for the treatment of neuropathic pain; REL-1028 BuTab, an oral tablet form of buprenorphine; REL-1015 LevoCap ER, an abuse resistant form of broad spectrum opioid levorphanol; and REL-1021 MepiGel, a topical gel dosage form of local anesthetic mepivacaine. Relmada Therapeutics also develops analgesics and anti-arthritic medicines. Its target treatment areas include chronic pain due to cancer, musculoskeletal disorders and peripheral neuropathy. Relmada Therapeutics is headquartered in New York, the US.

Relmada Therapeutics Inc Key Recent Developments

Jun 28, 2017: Relmada Therapeutics appoints new chair of scientific advisory board
Jun 21, 2017: Relmada Therapeutics appoints new executive clinical advisor
Jun 15, 2017: Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
May 18, 2017: Relmada Therapeutics Announces Settlement of Legal Action with Laidlaw & Company

This comprehensive SWOT profile of Relmada Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Relmada Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Relmada Therapeutics Inc - Key Information
  • Relmada Therapeutics Inc - Overview
  • Relmada Therapeutics Inc - Key Employees
  • Relmada Therapeutics Inc - Key Employee Biographies
  • Relmada Therapeutics Inc - Key Operational Heads
  • Relmada Therapeutics Inc - Major Products and Services
  • Relmada Therapeutics Inc - History
  • Relmada Therapeutics Inc - Company Statement
  • Relmada Therapeutics Inc - Locations And Subsidiaries
  • Relmada Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Relmada Therapeutics Inc - Business Description
  • Relmada Therapeutics Inc - Corporate Strategy
  • Relmada Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Relmada Therapeutics Inc - Strengths
  • Relmada Therapeutics Inc - Weaknesses
  • Relmada Therapeutics Inc - Opportunities
  • Relmada Therapeutics Inc - Threats
  • Relmada Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Relmada Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Relmada Therapeutics Inc, Key Information
  • Relmada Therapeutics Inc, Key Ratios
  • Relmada Therapeutics Inc, Share Data
  • Relmada Therapeutics Inc, Major Products and Services
  • Relmada Therapeutics Inc, History
  • Relmada Therapeutics Inc, Key Employees
  • Relmada Therapeutics Inc, Key Employee Biographies
  • Relmada Therapeutics Inc, Key Operational Heads
  • Relmada Therapeutics Inc, Other Locations
  • Relmada Therapeutics Inc, Subsidiaries
  • Relmada Therapeutics Inc, Key Manufacturing facilities
  • Relmada Therapeutics Inc, Key Competitors
  • Relmada Therapeutics Inc, SWOT Analysis
  • Relmada Therapeutics Inc, Ratios based on current share price
  • Relmada Therapeutics Inc, Annual Ratios
  • Relmada Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Relmada Therapeutics Inc, Performance Chart
  • Relmada Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown